Meeting
2023 ASCO Annual Meeting
Association of alterations in multiple tumor suppressor genes with poor outcomes in patients with EGFR-mutant lung cancer.
Authors
Paul Stockhammer
Yale School of Medicine, New Haven, CT
Paul Stockhammer , Michael J Grant , Anna Wurtz , Giorgia Foggetti , Francisco Expósito , Jianlei Gu , Sangyun Chung , Fangyong Li , Zenta Walther , Scott N. Gettinger , Katerina A. Politi , Sarah B. Goldberg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 9104)
DOI
10.1200/JCO.2023.41.16_suppl.9104
Abstract #
9104
Poster Bd #
92
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
First report of ELUCIDATOR study: A prospective observational multicenter study on resistance mechanisms in patients with early disease progression during osimertinib.
First Author: Yasuyuki Mizumori
Poster
2021 ASCO Annual Meeting
Genomic and immunologic characterization of large-cell neuroendocrine carcinoma of the lung.
First Author: Chul Kim
Poster
2020 ASCO Virtual Scientific Program
Study of anlotinib combined with icotinib as the first-line treatment in non-small cell lung cancer (NSCLC) patients harboring activating EGFR mutations (ALTER-L004).
First Author: Dingzhi Huang
Poster
2019 Gastrointestinal Cancers Symposium
Genomic alterations in appendiceal carcinoma using circulating DNA.
First Author: Walid Labib Shaib